Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
FivepHusion Announces Strategic Collaboration with Treehill Partners and Syneos Health 2023-05-26 13:42
Ascentage Pharma Presents Updated Results from Multiple Clinical Studies at American Society of Clinical Oncology Annual Conference 2023-05-26 10:01
Dizal's Oncology Pipeline Continues to Impress with Two Oral Presentations at 2023 ASCO Annual Meeting 2023-05-26 06:00
Daewoong Pharmaceutical Publishes Molecular Mechanism of Bersiporocin as an Antifibrotic in EMBO Molecular Medicine 2023-05-26 06:00
I-Mab Announces Encouraging Phase 1b/2 Study Results of Patients with Advanced NSCLC Receiving Uliledlimab and Toripalimab Combination Therapy at ASCO 2023 2023-05-26 05:01
Hepagene Therapeutics to Present at the European Association for the Study of the Liver (EASL) Congress 2023 2023-05-25 22:00
HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease 2023-05-25 19:00
Telix to Host Briefing with U.S. Leadership Team and Key Opinion Leaders to Highlight Innovation in Urology 2023-05-25 19:00
111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023 - Conference Call to Follow 2023-05-25 14:05
TYK2/JAK1 Inhibitor AC-201 of Accropeutics Bioscience gained Human Research Ethics Committees (HREC) permission for Phase I 2023-05-25 09:51
BioRay Filed IND Application for BRY812, a Novel Antibody Drug Conjugate Targeting LIV-1 2023-05-24 16:14
PharmAbcine Receives IND Approval from the Korean MFDS for Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD 2023-05-23 20:00
SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum 2023-05-23 20:00
Minghui Pharmaceutical Inc. Announces First-in-Human Dose of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody in Phase 1a Healthy Volunteer Study 2023-05-23 19:00
HanX Biopharmaceuticals announces HX009 IND approval from FDA 2023-05-22 22:00
WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations 2023-05-22 16:30
Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial 2023-05-19 21:00
Daewoong Pharmaceutical Presents New Clinical Data of Fexuprazan at Digestive Disease Week 2023 2023-05-19 20:00
HanAll Biopharma Announces Results from Phase III randomized, double-masked active treatment-controlled VELOS-3 Trial Evaluating Tanfanercept 0.25% for Treatment of Dry Eye Disease 2023-05-19 19:00
HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics 2023-05-18 21:30
1 31 32 33 34 35 148